Baliopharm - Ownership and Business Overview

Life ScienceCompany

Baliopharm Ownership

Who owns Baliopharm?

Baliopharm is owned by Alvotech. It was acquired on May 18, 2016.

Baliopharm Business Overview

Where is Baliopharm headquartered?

Baliopharm is headquartered in Juelich, Germany.

What sector is Baliopharm in?

Baliopharm is a life science company.

Life Science M&A Summary in 2016

Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2016. The largest life science acquisition in 2016 was Baxalta - which was acquired by Shire for $32.0B.

Subscribe to Mergr to view all 298 acquisitions of life science companies in 2016, including 35 acquisitions by private equity firms, and 263 by strategics.

Baliopharm GmbH

Karl-Heinz-Beckurts-Strasse 13,
Juelich, D-52428
Germany,
+49 2461 6210 855

Baliopharm GmbH is a biopharmaceutical development company.


 Subscribe to unlock this and 215,016
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore a company's M&A activity, ownership history, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.7K Private Equity Firms
  • 208K M&A Transactions
  • 210K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

What next?

Get Full Access

Full access to Mergr's investor, acquirer, and transaction data starts here.

Related Lists for Baliopharm

Life Science Companies